1 Jul 2025Open access3cites
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African PopulationPublisher siteHepatic Medicine Evidence and Research, Liver Disease Diagnosis and Treatment
Active, last published 2026
In liver disease diagnosis and treatment
Jean-Bonny
Nsumbu
Scholar“Research focused on Liver Disease Diagnosis and Treatment and adjacent fields.”
Université de Kinshasa (UNIKIN)
DR Congo
Claim Your ProfileDR Congo1
H-index
3
Citations
Jean-Bonny has not officially claimed their profile. If you are Jean-Bonny, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ean-Bonny Nsumbu is a researcher working on Liver Disease Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Jean-Bonny's work has been cited 3 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Liver Disease Diagnosis and Treatment×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Kinshasa, DR CongoDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works13 Apr 2025Open access
Frequency and determinants of fatty liver disease in Congolese population: interest of Fibroscan assessingPublisher siteAnnales Africaines de Medecine, Liver Disease Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Jean-Bonny?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you